These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 15460194)

  • 21. Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
    Sayyahfar S; Ansari S; Mohebali M; Behnam B
    Korean J Parasitol; 2014 Apr; 52(2):189-91. PubMed ID: 24850963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans.
    Dahal P; Singh-Phulgenda S; Maguire BJ; Harriss E; Ritmeijer K; Alves F; Guerin PJ; Olliaro PL
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009650. PubMed ID: 34375339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV.
    Borrelli P; Imperato A; Murdaca G; Scudeletti M
    Ann Ital Med Int; 2000; 15(2):169-71. PubMed ID: 10920508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital kala-azar: a case report.
    Sharma R; Bahl L; Goel A; Upadhaya A; Kaushik SL; Sharma RL; Gupta A
    J Commun Dis; 1996 Mar; 28(1):59-61. PubMed ID: 8778183
    [No Abstract]   [Full Text] [Related]  

  • 26. Relapse of kala-azar after use of multiple drugs: a case report and brief review of literature.
    Pandey K; Pun SB; Pandey BD
    Indian J Med Microbiol; 2012; 30(2):227-9. PubMed ID: 22664444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B.
    Dilber E; Erduran E; Işik Y
    Turk J Pediatr; 2002; 44(4):354-6. PubMed ID: 12458816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The first probable case of platelet transfusion-transmitted visceral leishmaniasis.
    Mathur P; Samantaray JC
    Transfus Med; 2004 Aug; 14(4):319-21. PubMed ID: 15285729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autochtonous kala-azar (author's transl)].
    Castel Y; Chastel C; Le Moigne C; Simitzis AM; Le Fur JM
    Arch Fr Pediatr; 1982 Feb; 39(2):97-8. PubMed ID: 7073440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
    Sundar S; Mehta H; Chhabra A; Singh V; Chauhan V; Desjeux P; Rai M
    Clin Infect Dis; 2006 Mar; 42(5):608-13. PubMed ID: 16447104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B.
    Erduran E; Bahadir A; Gedik Y
    Pediatr Hematol Oncol; 2005; 22(5):349-55. PubMed ID: 16020124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comment on: Unresponsiveness to AmBisome in some Sudanese patients with kala-azar.
    de Górgolas M
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):1054; author reply 1054-5. PubMed ID: 17651771
    [No Abstract]   [Full Text] [Related]  

  • 33. Imported leishmaniasis: a heterogeneous group of diseases.
    Pérez-Ayala A; Norman F; Pérez-Molina JA; Herrero JM; Monge B; López-Vélez R
    J Travel Med; 2009; 16(6):395-401. PubMed ID: 19930379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of kala-azar: a review with comments drawn from experience in Kenya.
    Rees PH; Kager PA; Ogada T; Eeftinck Schattenkerk JK
    Trop Geogr Med; 1985 Mar; 37(1):37-46. PubMed ID: 3874454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kala-azar--an endemic disease close to Switzerland. Apropos of 2 cases in children observed in Geneva].
    Thélin O
    Rev Med Suisse Romande; 1985 Apr; 105(4):363-8. PubMed ID: 2990003
    [No Abstract]   [Full Text] [Related]  

  • 37. Visceral leishmaniasis during pregnancy: A rare case report from Greece.
    Panagopoulos P; Mitsopoulos V; Papadopoulos A; Theodorou S; Christodoulaki C; Aloupogiannis K; Papantoniou N
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005134. PubMed ID: 28207741
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
    Murray HW
    Int J Infect Dis; 2000; 4(3):158-77. PubMed ID: 11179920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.